Viatris Innovation GmbH
23
1
3
17
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.3%
1 terminated/withdrawn out of 23 trials
94.4%
+7.9% vs industry average
22%
5 trials in Phase 3/4
24%
4 of 17 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (23)
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
Role: lead
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
Role: lead
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction
Role: lead
A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment
Role: lead
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus
Role: lead
A Trial to Evaluate the Absolute Bioavailability of Cenerimod in Healthy Male Participants
Role: lead
A Trial to Compare What the Body Does to Selatogrel and the Effect of Selatogrel in Japanese and Caucasian Healthy Participants
Role: lead
Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus
Role: lead
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus
Role: lead
Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441
Role: lead
To Study the Effect of Cenerimod on the Electrical Activity of the Heart, in Men and Women. To Study the Effect of Cenerimod on the Use of Oral Contraceptives in Women. To Study the Effect That Charcoal Has on the Elimination of Cenerimod From the Body, in Women and Men.
Role: lead
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of Cenerimod
Role: lead
A Study to Evaluate Cenerimod in Healthy Male Subjects
Role: lead
The Effect of Severe Kidney Impairment on Cenerimod Pharmacokinetics
Role: lead
Single Oral Dose of 4 mg Cenerimod in Healthy Japanese and Caucasian Subjects
Role: lead
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Heart Attack
Role: lead
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
Role: lead
The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics
Role: lead
A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects
Role: lead
A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects
Role: lead